Printer Friendly
The Free Library
14,528,975 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Austin Medical Technologies, Inc. Announces Its New Trading Symbol AMTV.


Business Editors & Health/Medical Writers

ST. PETERSBURG, Florida--(BW HealthWire)--Feb. 5, 2002

Austin Medical Technologies, Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
:AMTV AMTV Agrupación de Mujeres Tierra Viva (Womens' Group for the Living Earth, Guatemala) ) announced that the NASD NASD

See: National Association of Securities Dealers


NASD

See National Association of Securities Dealers (NASD).
 has issued a new trading symbol Trading symbol

See: Ticker symbol
. All current shareholders will be able to trade their current shares without having to replace them.

Mark Samardich, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Austin Medical Technologies, stated, "We are pleased to be trading under our new symbol AMTV provided to us by the NASD. We are actively pursuing becoming a fully reporting company in the near term."

About Austin Medical Technologies, Inc.

Austin Medical Technologies (AMTV) utilizes Web based technology, www.eyedirecti.com, to enable surgeons to design and purchase customized sterile surgical packs for LASIK LASIK laser-assisted in-situ keratomileusis.

LA·SIK
n.
Eye surgery in which the surface of the cornea is reshaped using a laser, performed to correct certain refractive disorders such as myopia.
, Cataract, Retinal and Plastic surgery. The company also distributes innovative products provided to it by leading manufactures of medical health care devices.

For investor relations contact investors@austinmedtech.com or call 972/370-0197.

The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this communication (as well as information included in oral statements or other written statements made or to be made by Austin Medical Technologies, Inc. or its wholly owned subsidiaries) contains statements that are forward-looking, such as statements relating to the future anticipated direction of the medical and technology industries and plans for future expansion, various business development activities, planned capital expenditures, future funding sources, anticipated sales growth and potential contracts. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of Austin Medical Technologies or its wholly owned subsidiaries. These risks and uncertainties include, but are not limited to, those relating to development and expansion activities, dependence on existing management, financial activities, domestic and global economic conditions, changes in federal or state tax laws, and market competition factors.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 5, 2002
Words:317
Previous Article:The Chrome Top 10 -- The Nation's Most Popular Vehicles; Honda Remains Top Choice of Online Auto Shoppers for the Month of January.
Next Article:New Journal, Biosecurity: The Journal of Biodefense Strategy, Practice, and Science to be Published by Mary Ann Liebert, Inc.



Related Articles
BioGenetic Announces U.S. Patent Office Approves Superior Cut 2 Patent.
AASI JETCRUZER Announces Progress Report on Development of Aircraft; Additional Aircraft for FAA Flight Testing Targeted for Assembly.
AASI Aircraft JETCRUZER 500 Passes FAA Window Tests and Prepares for Main Wing Tests; Main Wing Passes Company's Structure Test; Ready for FAA...
Austin Medical Technologies, Inc. Announces Appointment to the Board of Advisors: Richard Holdren, a Medical Industry Merger and Acquisition...
University of Texas at Austin Selects Valence's N-Charge Power System.
Valence Technology Accesses $5 Million of Equity Capital.
Cousins Signs 48,000-Square-Foot Lease at Congress at Fourth.
Cousins Signs Dewey Ballantine LLP to 35,000-square-foot Lease At Congress At Fourth; Top Ranked Global Law Firm to Establish Austin Office in...
Valence Technology Accesses $5 Million of Equity Capital.
Cousins Signs Frost Bank to Anchor Congress at Fourth.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles